# The Use of HOVR Technology for Assessment of Blood Associated Parameters

> **NCT05921461** · — · COMPLETED · sponsor: **Votis Subdermal Imaging Technologies LTD** · enrollment: 60 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Diabetes Mellitus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05921461
- **Lead sponsor:** Votis Subdermal Imaging Technologies LTD
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05921461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05921461, "The Use of HOVR Technology for Assessment of Blood Associated Parameters". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05921461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*